SK

Sekhar Kondapaturi

Active Director Designated Partner DIN 10828392
DIN 10828392 First appointment Nov 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sekhar Kondapaturi

Data last updated:

Sekhar Kondapaturi is a Designated Partner at Rocs Healthcare Llp (since 2024).

DIN 10828392
Primary Designation Designated Partner
First Appointment 05 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Nov 20242024Active

Board colleagues of Sekhar Kondapaturi

NameDINCompanyDesignation
Prabhavathi Kalla10986103Rocs Healthcare LlpDesignated Partner
Rajesh Maddala Kumar06945758Rocs Healthcare LlpDesignated Partner
Srinivasa Reddy Kotapati10828391Rocs Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rocs Healthcare Llp
Premium access

Shareholding and investment profile for Sekhar Kondapaturi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sekhar Kondapaturi

Sekhar Kondapaturi currently holds 1 directorship: Rocs Healthcare Llp (Designated Partner, since 05 Nov 2024).

Sekhar Kondapaturi was first appointed on 05 Nov 2024 as Designated Partner at Rocs Healthcare Llp.

The current boards of Sekhar Kondapaturi's companies include Prabhavathi Kalla (Rocs Healthcare Llp), Rajesh Maddala Kumar (Rocs Healthcare Llp), Srinivasa Reddy Kotapati (Rocs Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available